Bosentan in Children With Pulmonary Arterial Hypertension

Update Il y a 4 ans
Reference: NCT00319267

Woman and Man

Extract

The aim of the study is to demonstrate that the exposure to bosentan in children with idiopathic pulmonary arterial hypertension (PAH) or familial pulmonary arterial hypertension, using a pediatric formulation, is similar to that in adults with PAH and to evaluate the tolerability and safety of a pediatric formulation of bosentan in this patient population.


Inclusion criteria

  • pulmonary arterial hypertension


Links